The non-steroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria
Nephrology Dialysis Transplantation · 2026
DOI: 10.1093/ndt/gfaf232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2026. Verfasst von Rie Tatsugawa und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Okayama, Japan. Hauptthemen laut MEDLINE: Mineralocorticoid Receptor Antagonists, Albuminuria, Glomerular Filtration Rate, Pyrroles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Japan Society for the Promotion of Science, Kawasaki Medical School.
Abstract (Originalsprache)
Background
Diabetic kidney disease (DKD) is a major cause of chronic kidney disease, with glomerular hyperfiltration contributing to its progression. Esaxerenone, a non-steroidal mineralocorticoid receptor antagonist (MRA), reduces albuminuria, but its precise mechanism remains unclear. Mineralocorticoid receptor (MR) activation is implicated in tubuloglomerular feedback (TGF) dysregulation, and we hypothesized that MR inhibition attenuates albuminuria by mitigating glomerular hyperfiltration.
Methods
To investigate the effects of esaxerenone, we used aldosterone-induced MR activation rats and type 2 diabetic (db/db) mice. In vivo multiphoton imaging was performed to assess the single-nephron glomerular filtration rate (SNGFR) and arteriolar diameters. Macula densa (MD) cells were used to examine MR activation’s impact on TGF.
Results
In aldosterone-infused rats, MR activation induced glomerular hyperfiltration via afferent arteriolar dilation, which was attenuated by esaxerenone. In db/db mice, esaxerenone reduced SNGFR and urinary albumin excretion while increasing urinary adenosine levels, effects reversed by A1aR blockade. In MD cells, MR activation increased nitric oxide (NO) production and reduced Na+-K+-2Cl− cotransporter membrane expression, both of which were mitigated by MRA or neuronal nitric oxide synthase inhibition.
Conclusion
These findings suggest that esaxerenone restores TGF function via adenosine signalling, attenuating glomerular hyperfiltration and reducing albuminuria. This study provides novel insights into the albuminuria-lowering effects of MR blockade in DKD and supports the therapeutic potential of esaxerenone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Okayama, Japan.
- Department of Physiology and Neuroscience and Department of Medicine, Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, CA, USA.
- Division of Nephrology, Department of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada.
- Kawasaki Medical School, Kawasaki Geriatric Medical Center, Kurashiki, Okayama, Japan.
Förderung
- NIDDK NIH HHS
- Japan Society for the Promotion of Science
- Kawasaki Medical School
- Daiichi Sankyo
- CIHR
- Heart and Stroke Richard Lewar Centre of Excellence
- Heart and Stroke Foundation
- Kidney Foundation of Canada
Zitieren
APA
Tatsugawa, R., Kidokoro, K., Iwakura, T., Hirano, A., Kajimoto, E., Takasu, M., Wada, M., Kitao, H., Wada, Y., Gyarmati, G., Kishi, S., Nagasu, H., Cherney, D. Z. I., Peti-Peterdi, J., Sasaki, T., & Kashihara, N. (2026). The non-steroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf232
Vancouver
Tatsugawa R, Kidokoro K, Iwakura T, Hirano A, Kajimoto E, Takasu M, et al. The non-steroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria. Nephrology Dialysis Transplantation. 2026. doi:10.1093/ndt/gfaf232
BibTeX
@article{Tatsugawa2026,
author = {Tatsugawa, Rie and Kidokoro, Kengo and Iwakura, Tsukasa and Hirano, Akira and Kajimoto, Eriko and Takasu, Masanobu and Wada, Masafumi and Kitao, Hiroshi and Wada, Yoshihisa and Gyarmati, Georgina and Kishi, Seiji and Nagasu, Hajime and Cherney, David Z I and Peti-Peterdi, Janos and Sasaki, Tamaki and Kashihara, Naoki},
title = {The non-steroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria},
journal = {Nephrology Dialysis Transplantation},
year = {2026},
doi = {10.1093/ndt/gfaf232}
}
EUVIMED